Register for OBR daily


Kantar Health Conference Sidebar

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CRIS $1.98 0.1000 +5.32%
CYTK $4.26 0.0997 +2.40%
XNCR $9.80 0.2200 +2.30%
SNY $52.74 0.5550 +1.06%
APRI $1.92 0.0200 +1.05%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CBMG $20.66 -7.5101 -26.66%
VSTM $7.50 -0.6100 -7.52%
INO $10.26 -0.7700 -6.98%
MEIP $6.44 -0.4100 -5.99%
EPZM $31.55 -1.9900 -5.93%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Targacept Discontinues Bladder Drug, Shares Plunge

(Reuters) July 28, 2014 - Targacept Inc said it was stopping development of a drug to treat overactive bladder after it failed to show significant reduction in incontinence in a mid-stage study.
read article 



Drug Naming Process Gets New Scrutiny From FDA

(Roll Call/Healthopolis blog) July 29, 2014 - The Food and Drug Administration on Monday issued a notice seeking comments on the process of naming prescription drugs, particularly drug manufacturers’ desire to reserve a specific name for a drug product.
read article 



Docs Complain to CMS About ‘Sunshine’ Data Disclosures

(Wall Street Journal/Pharmalot blog) July 28, 2014 - A group of medical societies and pharmaceutical industry trade groups is pushing the government to flesh out data that will be published next month showing how much drug makers pay doctors.
read article (paid subscription required) 



2,500 Ground Zero Workers Have Cancer

(New York Post) July 27, 2014 - More than 2,500 Ground Zero rescuers and responders have come down with cancer, and a growing number are seeking compensation for their illnesses, The Post has learned.
read article 



Surgeon General Warning: Stop Tanning and Save Your Skin

(USA Today) July 29, 2014 - A call to action from acting Surgeon General Boris Lushniak, released Tuesday, says that skin cancer is a “major public health problem” and that too much exposure to indoor and outdoor ultraviolet light is a major cause.
read article 



FDA Commissioner Margaret A. Hamburg’s Statement on the Surgeon General’s Call to Action to Prevent Skin Cancer

(FDA.gov) July 29, 2014 - Each year, thousands of Americans are diagnosed with some form of skin cancer. The Surgeon General’s Call to Action to prevent skin cancer is important especially during these hot summer months when many of us spend extra time in the sun.
read press announcement 



Is America Treating Cancer the Wrong Way?

(Al Jazeera America) July 28, 2014 - Chemotherapy is big business, but some doctors say it could be overused and are pushing for cheaper and better care.
read article 



Ibrutinib in CLL: Indication Expanded, Benefit Confirmed

(Medscape Medical News) July 28, 2014 - Ibrutinib (Imbruvica, Pharmacyclics), hailed as a "turning point" in the treatment for chronic lymphocytic leukemia (CLL), has just had another indication and a label change approved by the US Food and Drug Administration (FDA).
read article (free registration required) 



Merck Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma

(Yahoo! Finance) July 29, 2014 - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC); mMCC is a rare and aggressive skin cancer lacking effective treatments.
read article 



Cancer Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation

(UT Southwestern) July 28, 2014 - UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.
read press release 



Quick, Low-cost Procedure Developed for Early Detection of Oral Cancer

(UTS [Sydney, NSW, Australia]) July 29, 2014 - UTS researchers have developed a simple blood test to detect the early signs of oral cancer at little cost. The test looks at the profile of small molecules called microRNA in the blood and can be done along with routine checks, such as cholesterol.
read article 



Scripps Florida Scientists Find Genetic Mutations Linked to Salivary Gland Tumors

(TSRI) July 28, 2014 - Research conducted at the Florida campus of The Scripps Research Institute (TSRI) has discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands.
read press release 



Statins Tied to Lower Risk of Barrett’s Esophagus

(New York Times/Well blog) July 28, 2014 - Cholesterol-lowering statin drugs are associated with a lower risk of Barrett’s esophagus, a precancerous condition that can sometimes lead to esophageal cancer, a new study has found.
read article 



Study Helps Compare Risks of Treatments for Early Esophageal Cancer

(Northwestern Medicine) July 28, 2014 - A new study, published in the July, 2014, issue of the Journal of the National Cancer Institute by Northwestern Medicine® researchers, sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.
read press release 



Roche's Gazyvaro Approved in Europe for Patients with the Most Common Type of Leukemia

(Roche) July 29, 2014 - Roche today announced that the European Commission has approved Gazyvaro (obinutuzumab) in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia who have comorbidities making them unsuitable for an intensive therapy (full-dose fludarabine based therapy). Outside of the EU and Switzerland, Gazyvaro is marketed as Gazyva.
read corporate press release 



House Passes Bill to Speed FDA's Sunscreen Approvals

(Wall Street Journal) July 28, 2014 - The House passed legislation Monday to require the Food and Drug Administration to speed approval of new types of sunscreen in the wake of a regulatory backlog that has stalled their introduction.
read article (paid subscription required) 



FDA Expands Approved Use of Imbruvica for Chronic Lymphocytic Leukemia

(FDA.gov) July 28, 2014 - The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
read press release 



Slower U.S. Healthcare Cost Rise Extending Life of Medicare Fund: Trustees

(Reuters) July 28, 2014 - Slower growth in U.S. healthcare spending and expected savings from Obamacare are shoring up the funding outlook for the federal Medicare program that covers the hospital bills of the elderly, trustees of the program said on Monday.
read article 



Ebola Is Only a Plane Ride Away from Other Countries

(USA Today) July 28, 2014 - The growing Ebola outbreak in West Africa serves as a grim reminder that deadly viruses are only a plane ride away from the USA, health experts say.
read article 



Longtime BSX-J&J Feud Heading to Trial

(Boston Globe/New York Times) July 28, 2014 - Johnson & Johnson and Boston Scientific have been at odds for nearly a decade. Now that dispute has quietly resurfaced.
read article (free registration required) 



FDA Rejects AcelRx Painkiller Dispensing Device

(TheStreet) July 28, 2014 - AcelRx Pharmaceuticals failed to secure FDA approval for its painkiller dispensing device Zalviso. AcelRx disclosed the FDA rejection late Friday.
read article 



The Lessons Thus Far From the Transition to Digital Patient Records

(New York Times/Bits blog) July 28, 2014 - A new research paper, published in this month’s issue of Health Affairs, only adds to the confusion.
read article 



Medicare Pressed to Bargain on Drug Costs

(MedPage Today/Kaiser Health News) July 26, 2014 - Medicare could save billions if Congress overcame its reluctance to anger the drug industry and allowed the program to demand rebates or negotiate prices, according to Rep. Henry Waxman (D-Calif.).
read article (free registration required) 



Many Local Patients Still Turn Elsewhere for Care

(Scranton Times-Tribune) July 27, 2014 - For nearly two years — starting on Dec. 21, 2011, when Kelcey Hallinan was diagnosed with Hodgkin lymphoma to shortly before her death on Nov. 16, 2013 — Philadelphia became the Hallinan family’s second home.
read article 



The Myeloma Quiz – July 2014

(The Myeloma Beacon) July 23, 2014 - It’s July, and we have had some time to digest the findings from the American Society of Clinical Oncology (ASCO) annual meeting held in Chicago May 30 through June 3. It's time to take another short quiz to test your knowledge about the key ASCO takeaways.
read article